medigraphic.com

2023, Number 4

Next >>

Enf Infec Microbiol 2023; 43 (4)

From the editors

Volkow Fernández P, Martin-Onraet A

Language: Spanish
References: 15
Page: 133-136
PDF size: 223.84 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Lazarus, J.V., Safreed-Harmon, K., Barton, S.E., Costagliola,D., Dedes, N., Del Amo Valero, J., Gatell, J.M.,Baptista-Leite, R., Mendão, L., Porter, K., Vella, S. y Rockstroh,J.K., “Beyond viral suppression of hiv: the newquality of life frontier”, bmc Med, 2016, 14 (1): 94. doi:10.1186/s12916-016-0640-4.

  2. Marcus, J.L., Leyden, W.A., Alexeeff, S.E. et al., “Comparisonof overall and comorbidity-free life expectancybetween insured adults with and without hiv infection,2000-2016”, jama Netw Open, 2020, 3 (6): e207954.

  3. Wei, F., Gaisa, M.M., D’Souza, G., Xia, N., Giuliano, A.R.,Hawes, S.E., Gao, L. et al., “Epidemiology of anal humanpapillomavirus infection and high-grade squamousintraepithelial lesions in 29 900 men according to hiv status,sexuality, and age: a collaborative pooled analysisof 64 studies”, Lancet hiv, 2021, 8 (9): e531-e543.

  4. Liu, G., Sharma, M., Tan, N. y Barnabas, R.V., “hiv-positivewomen have higher risk of human papilloma virusinfection, precancerous lesions, and cervical cancer”,aids, 2018, 32 (6): 795-808.

  5. Brent, G., Oghenowede E., Hull, M.W. Samji, H., Zhang,W., Sereda, P., Lima, V.D., McGrail, K., Montaner, J.S.G.,Hogg, R.S., Moore, D. y the coast Study Team, “Incidenceof select chronic comorbidities among a population-based cohort of hiv-positive individuals receivinghighly active antiretroviral therapy”, Current MedicalResearch and Opinion, 2019, 35 (11): 1955-1963.

  6. Bonnet, F., Le Marec, F., Leleux, O. et al., “Evolution ofcomorbidities in people living with hiv between 2004and 2014: cross-sectional analyses from anrs co3 Aquitainecohort·, bmc Infect Dis, 2020, 20: 850 .

  7. Serrão, R., Piñero, C., Velez, J., Coutinho, D., Maltez,F., Lino, S., Sarmento e Castro, R., Tavares, A.P., Pacheco,P., Lopes, M.J., Mansinho, K., Miranda, A.C.,Neves, I., Correia de Abreu, R., Almeida, J. y Pássaro,L., “Non-aids-related comorbidities in people living withhiv-1 aged 50 years and older: The aging positive study”,Int J Infect Dis, 2019, 79: 94-100.

  8. Jiménez, Z., Sánchez-Conde, M. y Brañas, F., “La infecciónpor vih como causa de envejecimiento aceleradoy fragilidad”, Rev Esp Geriatr Gerontol, 2018, 53 (2):105-110.

  9. Clinicalinfo, hiv.gov, “Guidelines for the use of antiretroviralagents in adults and adolescents with hiv”.Disponible en: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hiv-and-older-person?view=full. Fecha de consulta: 4de octubre de 2023.

  10. European aids Clinical Society, “Guidelines 2022”.Disponible en: https://eacs.sanfordguide.com/prevention-non-infectious-co-morbidities/co-morbidities-overview. Fecha de consulta: 4 de octubre de 2023.

  11. Centro Nacional para la Prevención y el Control del vih/sida (censida), “Guía para la atención de personas adultasmayores que viven con vih, 2018”. Disponible en:https://www.gob.mx/censida/documentos/guia-para-la-atencion-de-las-personas-adultas-mayores-queviven-con-vih?idiom=es. Fecha de consulta: 14 deseptiembre de 2023.

  12. Frey, E., Johnston, C.D. y Siegler, E.L., “Treatment regimensand care models for older patients living withhiv: are we doing enough?”, hiv aids (Auckland), 2023,15: 191-208.

  13. Guaraldi, G., Milic, J. y Mussini, C., “Aging with hiv”, Currhiv/aids Rep, 2019, 16 (6): 475-481.

  14. Erlandson, K.M. y Karris, M.Y., “hiv and aging: reconsideringthe approach to management of comorbidities”,Infect Dis Clin North Am, 2019, 33 (3): 769-786.

  15. Centro Nacional para la Prevención y el Control delvih/sida (censida), “Guía de manejo antirretroviral de laspersonas con vih, 2021”. Disponible en: https://www.gob.mx/censida/documentos/guia-de-manejo-antirretroviral-de-las-personas-con-vih-mexico-2021-297710.Fecha de consulta: 4 de octubre de 2023.




2020     |     www.medigraphic.com